Russell Investments Group, Ltd.
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 1692234
Seattle, WA
Position in XENE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$9,248,779
+$1,724,230 QoQ
Shares Held
153,227
+18.4% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#95
of 314 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. XENE ranks #41 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in XENE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,248,779 | 153,227 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $7,524,549 | 129,399 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $3,864,377 | 86,220 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,806,161 | 69,892 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,631,854 | 52,136 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,527,688 | 75,341 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,376,881 | 213,696 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $8,803,681 | 223,614 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,349,520 | 162,850 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $7,667,160 | 178,099 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $8,027,612 | 174,286 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $5,786,293 | 169,388 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,792,554 | 150,456 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $3,054,961 | 85,358 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,325,130 | 84,330 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $3,576,570 | 99,074 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $3,282,286 | 107,899 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $2,259,702 | 73,919 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,629,821 | 52,171 | Shares | Defined | 2022-01-21 | |
| No filing history on record for this holder in this stock. | ||||||